Funding helps develop screening and validation tools for functional genomics, cell line engineering and synthetic biology
PSI products complement existing genomics offering
LGC announced that it has appointed Brian Kim as Managing Director, Genomics, leading the group’s international Genomics division.
LGC announces that it has acquired a majority stake in Douglas Scientific
LGC obtains license for the commercial offering and use of KeyGene's patented SBG technology across all species
Novel precipitation-chemistry system fully automates whole blood genomic DNA isolation from primary tubes to final DNA storage tubes
LGC operates out of 22 countries, with laboratories and centres across Europe and the US, as well as sites in Brazil, China and India.